Navigation Links
Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
Date:11/4/2008

leader in research on myeloperoxidase and atherosclerosis. Dr. Hazen is lead investigator and a co-inventor of the Cleveland Clinic research team that discovered blood MPO levels serve as a diagnostic marker for cardiovascular disease risk and a monitor of responses to cardiac and anti-inflammatory therapies.

Under the terms of the agreement, Inverness will have co-exclusive worldwide distribution rights with PrognostiX in all countries except Italy and Russia. PrognostiX previously secured distributors in these two countries. Financial terms of the agreement were not disclosed.

"PrognostiX is delighted to be partnering with Inverness on the commercialization of our CardioMPO(TM) Test," said Jake Orville, president and chief executive of PrognostiX. Inverness is well known for both its commitment to delivering innovative diagnostics and its strong global sales and marketing organization. We look forward to a long, successful relationship with Inverness that is built on both."

About Inverness Medical Innovations Inc.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com.

About PrognostiX Inc.

PrognostiX, a privately-held spin out of the Cleveland Clinic, develops and markets next-generation cardiovascular disease diagnostic products. The company's CardioMPO(TM) test, which aids in the diagnosis of near-term heart attack and cardiac death risk, is
'/>"/>

SOURCE Inverness Medical Innovations Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Inverness Medical Innovations to Present at the Third Annual JMP Securities Healthcare Focus Conference on October 7, 2008
2. Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
3. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.
4. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results
5. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
6. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
7. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 20, 2008 to Discuss Fourth Quarter 2007 Results
8. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
9. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
10. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
11. Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., STANFORD, Calif. A new study shows that musc...,s ability to squeeze shut properly. The work, per...at patients with conditions such as gastric reflux... used to strengthen sphincters, which are the band...ur intestinal tract. Weakness in these areas can c...
(Date:12/4/2009)...kville, MD "Why is it that men can be bastards a... Lynn Hecht Schafran. The answer, according to an ... interpretation of facial expressions. , In two ...e sex of a series of faces. In the first study, an...ps (angry expressions) were more likely to be iden...
(Date:12/4/2009)...a response to pressure from federal regulators to ... , FRIDAY, Dec. 4 (HealthDay News) -- The maker...ay presented federal regulators with plans to curb...ceutical companies have been under pressure from U... a way to stop the hundreds of fatal overdoses tha...
(Date:12/4/2009)...er the H1N1 virus will come back during winter isn...(HealthDay News) -- The number of states reporting...e this week -- to 25 from a high of 48 just two we...Meanwhile, the supply of H1N1 swine flu vaccine co...or of the U.S. Centers for Disease Control and Pre...
(Date:12/4/2009)... study found they spurred blood vessel growth afte...hDay News) -- Adult stem cells appear to help repa...e phase 1 study of 53 patients found that stem cel...ew blood vessels in heart tissue damaged by heart ...njections within 10 days of having a heart attack....
Breaking Medicine News(10 mins):Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Are angry women more like men? 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Swine Flu Continues to Wane 2
...n Kile and David Huang found that two important mo...iscovery is sure //to raise the hope of formulatin...telets stored in blood banks. This will in turn in...potentially life-threatening bleeding. This is cau...
...en a choice of exercising alone, with people young...adults would rather exercise with others in their ... useful insight into the preferences of older exer...uchamp, Ph.D., an assistant professor in the Schoo...
...ut with study results that encourage health care p...nodes// marked by the presence of tumor cells in...is, researchers opine, may be a definite clue to c...is important for determining the prognosis and fut...
...l candidate John Edwards’ wife Elizabeth Edwards h...t cancer. This time it is located in the right rib...IV cancer. Mrs. Edwards, who battled breast ca...ht medical treatment for pain on her left side. Wh...
...hat improving the institutional culture (ethos) of... habits like// smoking, drinking, drug abuse and t...don School of Hygiene and Tropical Medicine's Cent...ng responses to these issues seem to have brought ...
...hursday ruled that all private hospitals, built on...ree of cost both at// their indoor and outdoor fac... While holding free treatment to the poor "oblig...provide free treatment upto 25 percent of their ou...
Other Medicine News:Health News:Improved Platelet Life Span Increases Better Patient Care 2Health News:Exercising With Peers Has Added Appeal 2Health News:Doctors Warned to Keep Track of Tumorous Lymph Nodes 2Health News:Doctors Hopeful for Elizabeth Edwards 2Health News:Improve School Ethos to Combat Teen Evils 2Health News:Private Clinics on Public Land Must Treat Poor Free: Court 2
(Date:12/4/2009)... , TARRYTOWN, N.Y., Dec. 4 /PRNewswire/ ...rand prize winners of Bayer,s "Express Your Simple... Brothers, selected the winning video entries subm...untry. The grand prize is an in-person meeting tod... diabetes like Nick, are: Caleb, age 6, from Danbu...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-Fir...ced that the US Food and Drug Administration (FDA)...pine fumarate) Extended Release Tablets as adjunct...s with Major Depressive Disorder (MDD). SEROQUEL X...the FDA to treat both major depressive disorder as...
(Date:12/3/2009)... , ACTON, Mass., Dec. 3 /PRNewswire-FirstC...l-Rom Holdings, Inc. (NYSE: HRC ), today announc...iginal Equipment Manufacturer) business website ...ces the Allen Amatech(TM) brand identity and inclu...with detailed descriptions and design specificatio...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Proper Physician Relationship Management Ensures Hospital Stability and Vitality 52767 1Proper Physician Relationship Management Ensures Hospital Stability and Vitality 52767 2Canada Grants PLC Systems First Patent for RenalGuard 28R 29 52762 1Canada Grants PLC Systems First Patent for RenalGuard 28R 29 52762 2Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression 4783 1Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression 4783 2Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression 4783 3
... The ERATO study,published today in the American H...atients with permanent atrial fibrillation, that d...24 hour ventricular rate, on top of,other rate con...7 beats per,minute (p< 0, 0001) with dronedaro...nt and highly statistically significant. This,rate...
...ial showed prasugrel substantially reduced, risk o...clopidogrel among ACS patien...nts who were,diabetic and diagnosed with acute cor...to suffer a heart attack if they were treated with...up analysis of the TRITON-TIMI 38,trial (8.2 perce...
Other Medicine Technology:American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation 2American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation 3Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 2Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 3Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 4Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 5
ManuTrain
... combines the therapeutic benefits of controlled c...and cold to minimize pain. The versatile design of... hand coverage. ,For added support, support bars ... a wider range of motion is desired.,All Cryo/Cuf...
Cindy Wrist Support
...nel Splint immobilizes and positions the elbow at ...tricts full extension and flexion to minimize stre...and irritation due to contracture. Also for ulnar ...high-density beige polyethylene shell with plush 3...
Medicine Products: